使用多层技术在中面RHA4的安全性和性能:临床前和临床证据
Killian Flégeau1, Stefania Ballarini2, Romain Brusini1
1From the Research and Development Department, Teoxane SA, Geneva, Switzerland.
Plastic and reconstructive surgery. Global open
|February 24, 2025
概括
弹性氨酸 (RHA) 填充剂RHA4有效地抬起面部组织,并与脂肪组织集成. 这项研究证实了其对动态面部区域的安全性和自然外观结果.
科学领域:
- 审美医学是一种美学医学.
- 皮肤病学 皮肤病学
- 生物材料科学 生物材料科学
背景情况:
- 弹性氨酸 (RHA) 填充剂用于动态纹和面部组织提升.
- RHA4是一种专为动态面部区域而设计的特定体积填充剂,支持组织.
- 这项研究研究了RHA4与人体皮下脂肪组织 (AT) 的相互作用.
研究的目的:
- 评估RHA4.4的生物,生物机械和临床安全性和性能.
- 评估RHA4与人体皮下脂肪组织 (AT) 的相互作用.
- 确定RHA4在动态面部区域的组织支和提升中的有效性.
主要方法:
- 用纤维细胞和脂肪干细胞进行体外细胞兼容性测试.
- 一年老鼠体内植入研究以评估组织整合和降解.
- 用多层技术对35名患者进行皮下AT的生物力学测试和临床评估.
主要成果:
- RHA4显示出优异的生物相容性和体外/体内组织集成,炎症最小.
- 填充剂促进了原蛋白束的形成,细胞外基质的存在,新血管化和AT的生长.
- 从临床角度来看,RHA4在不影响面部表情的情况下,对中脸提升是安全有效的.
结论:
- RHA4是一种多功能填充剂,可有效地进行深层和表面组织提升,特别是多层.
- 填充剂保留脂肪组织的生物力学,并适应面部动态,以获得自然的结果.
- 临床前和临床数据支持RHA4在美容面部治疗中的安全性和有效性.
相关概念视频
Hazard Ratio
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial evaluating a...
For example, in a clinical trial evaluating a...
Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...


